Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001999371-24-012102
Filing Date
2024-09-18
Accepted
2024-09-18 17:02:31
Documents
1
Period of Report
2024-09-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 13099
  Complete submission text file 0001999371-24-012102.txt   15923
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
BONDERMAN DAVID (Reporting) CIK: 0000860866 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 241308216

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
COULTER JAMES G (Reporting) CIK: 0001099776 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 241308215

Mailing Address C/O GOLDMAN, SACHS & CO. 85 BROAD STREET NEW YORK NY 10004
Business Address
WINKELRIED JON (Reporting) CIK: 0001366946 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 241308214

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 (817) 871-4000
TPG GP A, LLC (Reporting) CIK: 0001903793 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 241308217

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)